Commercialization: Page 10
-
PharmaVoice Team/PharmaVoice
SHOWCASE: Supply Chain: Addressing Supply-Chain Vulnerabilities
After COVID-19, pharma companies are eyeing different ways to ensure their supply chains remain resilient to future disruptions. When the world was hit by the COVID-19 pandemic, supply chains around the world faced almost instant disruption. The pandemic exposed vulnerabilities and highlighted th...
By PharmaVoice Team • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
The Cost of Overlooking Ancillary Supplies in Protocol Development
Recent upheaval in the global supply chain can no longer be seen through a crisis-control lens. It is a new reality forcing leaders, teams, and entire organizations to fundamentally change their approaches. It is arguable that the impacts are felt most acutely in pharma, where delays carry coloss...
By Joanne Santomauro • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
Opinion
Executive Perspective: Data For Better Health Outcomes: A Conversation with Clark Wooten and Anthony Passarelli
The COVID-19 pandemic has continued to disrupt the healthcare market across all sectors, and the digital health segment is no exception. But in this case, there has been a positive boost. According to Global Market Insights, the digital health market exceeded $141.8 billion in 2020 and is estimat...
By Clark Wooten • Nov. 15, 2021 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
Optellum and J&J Initiative Partner on Lung Health AI-driven Clinical Decision Platform Trend Watch: AI Continues to Accelerate R&D Efforts Across Diseases States Optellum, a lung-health AI company, has entered a strategic collaboration with the Lung Cancer Initiative at Johnson & Joh...
By PharmaVoice Team • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Artificial Intelligence: AI Here and Now
Companies have increasingly turned to machine learning and AI to improve R&D, manage costs, and address stakeholder expectations. Artificial intelligence and machine learning are no longer futuristic innovations. Today, AI is widely used within the pharmaceutical industry, with the market exp...
By PharmaVoice Team • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence, Buyer-Intent Data, and Account-Based Marketing: How Technology Has Changed the Way We Do B2B Marketing and Sales
The new world of B2B marketing is now shaped by data-driven decision-making by way of artificial intelligence (AI) and buyer-intent data. These two technologies allow for better understanding of what your customers want and can help you discover hidden business opportunities in near “real time." ...
By Jonathan Agoot • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
AI: Rewriting the Clinical Development Handbook
The life-sciences industry is at a critical and unprecedented inflection point in terms of AI. Since the start of the global pandemic the use of AI by biopharma has gone from tactical to transformational. Traditionally employed during the research phase of R&D to identify drug candidates, syn...
By Jonathan Burr • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Patient Engagement: Digital Control: Putting Solutions Into the Hands of Patients
Patient engagement solutions are key to clinician-patient interaction, improving compliance, enabling real-time reporting, and reducing visits to the doctor and hospital. Patients today want and expect to have greater control over their healthcare journey. They are accustomed to accessing informa...
By PharmaVoice Team • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
From Mass Marketing to Precision Marketing: The Revolution Is Now
The time is now — patients have firmly established themselves as savvy and engaged consumers. And they are becoming more empowered every day — with more access to research and information, online connections to other patients like themselves, and demanding more from a healthcare system that was a...
By Heather Campbell • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Real-World Implications of High-Deductible Health Plans
High deductible health plans (HDHPs) were created 20 years ago to foster a more consumer-driven and affordable healthcare landscape. Have they lived up to that vision? While these plans are beneficial for certain populations, new research suggests they may also play a role in broadening the exist...
By Bonnie MK Donato • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Bridging the Patient Support Gap With Integrated Technology Solutions and Strategies
Each year, medication non-adherence causes 125,000 preventable deaths and $300 billion in avoidable healthcare costs. In a world where patients face more medication barriers than ever, patient support programs are critical in providing value-based care that yields a palpable and lasting impact. T...
By Maria Kirsch • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Social Health: Reinventing the Patient Journey
Welcome to the next generation of the patient journey. It’s a journey that’s no longer vaguely linear — patients are now benefiting from practically infinite human connections enabled and accelerated by digital communication. Those connections have transformed the patient journey from a path to a...
By Jack Barrette • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Three Steps to Innovate Patient Solutions
At the heart of all of our work is meeting patient needs, so let’s take a deep dive into all of the routes currently available to deliver patient solutions. The challenge is to balance the conversation between pragmatism and idealism. To call out the elephant in the room, there’s a big appetite f...
By Corina Kellam • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
The Key Elements to a Successful and Sustainable Patient Engagement Strategy
There are three elements to a successful and sustainable patient engagement strategy: personalized, convenient, and data-driven. Pharma spends $20 billion a year in advertisements driving patients to the noninteractive CTA, “talk to a doctor." By incorporating these three elements, we can transfo...
By Chase Feiger • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Commercial Influencers
Influencers have the power to positively change the status quo because of their authority, knowledge, position, or relationship with their audience. The pandemic accelerated providers’ improvements in digital experiences so they could maintain their relationships with patients through the challen...
By PharmaVoice Team • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Jen Clark — Navigating Beyond For Commercial Success
By guiding healthcare clients to breakthrough strategy and impossible-to-ignore creative, they leave behind the expected and realize the exceptional. The advantage of covering the entire healthcare ecosystem, according to Jen Clark, VP, strategic planning at Purohit Navigation, is that her compan...
By Jen Clark • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Daniel Gilman — Smarter Connections Health Tech Innovation
Innovation in medical technology moves at an incredible pace, but providers cannot keep up. RxVantage is on a mission to change this so every provider has the most relevant information needed to deliver the best care to every patient. The demands of healthcare practices have made a HCP’s availabi...
By Daniel Gilman • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Client-Agency Partnerships
The secret sauce of successful agency-client teams: transparency, authenticity, and understanding. THE DUO Cynthia Accuosti Jones Janssen Oncology Ericka Wilhelms McKenna 21GRAMS, part of Real Chemistry Cynthia Jones, director of marketing, prostate portfolio, at Janssen Oncology, and Ericka McK...
By Robin Robinson • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Leveraging The Power of AI To Drive Marketing Performance
Artificial Intelligence (AI) is the technology that everyone is talking about. The big names in Silicon Valley hold dazzling keynotes to showcase the incredible ways they leverage AI to improve their products, and the mainstream press is littered with stories of AI discovering new drugs, helping ...
By Bryan O'Malley • Oct. 1, 2021 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Who you gonna call? Alexa, Echo, Siri, et al … voice assistants to the rescue? Or not? Let’s face it, we all engage our smart tools to do everything from changing the channel to ordering groceries to finding out which team won the ballgame to setting the temperature and lights. The time has now c...
By Taren Grom • Sept. 1, 2021 -
PharmaVoice Team/PharmaVoice
Upfront
GTO and Honeycomb Team Up to Raise Money for Rare Disease The Greater Than One Group (GTO) and its non-profit subsidiary Honeycomb Health conducted a cross-country road trip to raise money for the rare disease cause. In August, Rebecca Trahan began her trip to raise money for Honeycomb Health, a ...
By PharmaVoice Team • Sept. 1, 2021 -
PharmaVoice Team/PharmaVoice
HealthTech
McKinsey: Telehealth Use 38 Times Higher Than Pre-COVID-19 Use Trend Watch: Telehealth Gets a Push from COVID-19 Overall use of telehealth is at levels 38 times higher than before the COVID-19 pandemic, ranging from 13% to 17% of visits across all specialties, according to a recent McKinsey repor...
By PharmaVoice Team • Sept. 1, 2021 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
University of Washington Researchers Create AI Platform for Predicting Protein Folding Trend Watch: AI Partnerships and Open-Source Data Advance Drug Development The lab of David Baker at the University of Washington’s Institute for Protein Design has released its application to solve one of the ...
By PharmaVoice Team • Sept. 1, 2021 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Big Data: Pharma Leads the Way with Big Data Investment
As the pandemic creates urgency, the pharmaceutical industry is pushing ahead on data-driven solutions. Life-sciences companies are embracing big data as a way to drive innovation, with some indications that the industry has moved more aggressively on implementing data-led solutions in the past y...
By PharmaVoice Team • Sept. 1, 2021 -
PharmaVoice Team/PharmaVoice
Big Healthcare Drives a Better Patient Experience
Five ways real-world data adds value in the drug development and commercialization lifecycle. The drug development industry has access to vast stores of real-world data (RWD) that reflect the healthcare journeys of millions of patients across the globe. And the scale of these assets grows exponen...
By Mark Brown • Sept. 1, 2021
Previous
